A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 38/16 (2006.01) A61K 38/22 (2006.01) A61K 47/48 (2006.01) C07K 1/10 (2006.01) C07K 14/505 (2006.01)
Patent
CA 2497960
Methods for increasing the hematocrit of an individual while maintaining the tissue protective activities of endogenous through the administration of a pharmaceutical compound containing chemically modified long acting erythropoietin. Also disclosed are the new chemically modified long acting erythropoietins, methods of producing the chemically modified long acting erythropoietins, and compositions comprising the chemically modified long acting erythropoietins.
L'invention porte sur des procédés visant à augmenter le taux des hématocrites chez un individu tout en maintenant l'activité protectrice du tissu d'une érythropoïétine endogène en administrant un composé pharmaceutique contenant une érythropoïétine à action longue modifiée chimiquement. L'invention porte également sur de nouvelles érythropoïétines à action longue, modifiées chimiquement, sur leurs procédés de production et sur les compositions les comprenant.
Brines Michael
Cerami Anthony
Cerami Carla
Smart John
Johnston Wassenaar Llp
Kenneth S. Warren Institute Inc.
Warren Pharmaceuticals Inc.
LandOfFree
Long acting erythropoietins that maintain tissue protective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long acting erythropoietins that maintain tissue protective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting erythropoietins that maintain tissue protective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1904050